Literature DB >> 18816604

Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.

Samar Kerkeni, Hubert Marotte, Pierre Miossec.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18816604     DOI: 10.1002/mus.21047

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  4 in total

Review 1.  Myasthenia gravis: an update for the clinician.

Authors:  J P Sieb
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 2.  Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.

Authors:  Raffaele Iorio; Valentina Damato; Paolo Emilio Alboini; Amelia Evoli
Journal:  J Neurol       Date:  2014-10-12       Impact factor: 4.849

3.  Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report.

Authors:  Josef Finsterer; Sonja Höflich
Journal:  J Med Case Rep       Date:  2010-11-08

Review 4.  Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.

Authors:  Riccardo Bixio; Davide Bertelle; Francesca Pistillo; Elisa Pedrollo; Antonio Carletto; Maurizio Rossini; Ombretta Viapiana
Journal:  Clin Rheumatol       Date:  2022-01-14       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.